- Split View
-
Views
-
Cite
Cite
A. Ryan, S. Wilson, S. Greenfield, S. Clifford, R. J. McManus, H. M. Pattison, Range of self-tests available to buy in the United Kingdom: an Internet survey, Journal of Public Health, Volume 28, Issue 4, December 2006, Pages 370–374, https://doi.org/10.1093/pubmed/fdl051
- Share Icon Share
Abstract
We aimed to describe the availability in the United Kingdom of self-tests that are used to diagnose or screen for conditions without involving a health professional. A systematic Internet search identified 104 unique self-tests related to 24 named conditions including cancers, chronic conditions and infections. These self-tests require various samples including blood obtained using a lancet. The samples are processed at home with results available in minutes or sent to a laboratory for processing with results returned to the individual by e-mail or post. Prices per self-test and condition range from <£1 to £76. Self-tests are readily available, and further work is needed to assess their impact.
Introduction
As technologies to design and manufacture diagnostic tests have developed, a range of self-tests to diagnose or screen for conditions have become available to the public to buy over the counter and via the Internet.1 These self-tests do not require the user to communicate with a doctor before obtaining the test or when receiving the results: the results are available at home within minutes or a sample is sent to a laboratory and the results are returned directly to the user.
Self-tests have potential benefits, for example privacy or convenience, but also potential harms such as the distress caused by false-positive results.2 Despite the potential impact of self-tests, a comprehensive literature review identified only one recent survey in the United Kingdom that asked participants about whether they had used home-testing kits, and this was part of a study on attitudes to genetic testing.3 This lack of information, other than market research, led us to plan a study to describe the prevalence of the use of self-tests. To inform the design of this study, we undertook a systematic Internet search to identify self-tests that are available in the United Kingdom.
Methods
About 95% of searches in the United Kingdom are powered by four search engines: Google, Yahoo, MSN and Ask.4 In April 2006, we used these search engines to search the web for (self test OR self diagnosis OR home test OR home diagnosis) and each term individually. The entire web was searched, rather than just UK sites, to ensure that tests that are sold from other countries to UK customers were also identified. Because ∼70% of users move on if they have not found what they are looking for on the first two pages,5 we reviewed descriptions of the first 20 sites returned from each search and any sponsored sites on those pages. Sites that were obviously not relevant and directories were excluded, and the remaining sites were explored in April and May 2006.
We collected details of tests that, based on the description given, met the inclusion criteria and did not meet the exclusion criteria. A test was included if it could be purchased and used by a member of the UK public without involving a doctor, nurse or other health professional; if it detected a disease or condition that may need treatment or a risk factor or marker for such diseases or conditions; and if it required the user to take a sample and process it at home or send it to a laboratory with results returned by post or e-mail. A test was excluded if it could not be purchased by a member of the UK public, including if it was reported as being out of stock; if it was for pregnancy, other normal states or monitoring existing conditions; if it was only sold in large batches, unless it was specifically stated that the test was for home use; if purchase required approval from a health professional, a prescription or correctly answered screening questions; or if it required a separate meter or testing device.
Costs were collected including shipping and tax where this information was given. Some self-tests were sold in packs or were for more than one condition, and the cost per test and condition was calculated. Where prices were only given in dollars, they were converted to pounds using the exchange rate at the beginning of May 2006 (£1 = $1.82).
Results
We collected details of 167 self-tests, which were advertised by 19 retailers. Nine retailers were based in the United Kingdom, seven in the United States, one in the Netherlands, one in Taiwan and one did not state where they were based.
Some self-tests were sold by more than one retailer, and there were 104 unique tests. These tests relate to 24 named conditions (Table 1) including cancers (e.g. tests for faecal occult blood and prostate-specific antigen), chronic conditions (e.g. tests related to diabetes and cardiovascular disease), acute infections (e.g. tests for urinary and sexually transmitted infections) and serious chronic infections (e.g. tests for HIV infection). Self-tests related to male and female infertility and allergies were also available. Some self-tests were for more than one condition, for example, chlamydia and gonorrhoea.
Condition described as being related to the self-test . | Sample required . | Self-test described as detecting . | Processed at . | Cost per test and condition (£) . | . | Number . | . | ||
---|---|---|---|---|---|---|---|---|---|
. | . | . | . | Minimum . | Maximum . | All . | Unique . | ||
Allergy | Blood obtained with lancet | IgE | Home | 10 | 12 | 13 | 6 | ||
Blood obtained with lancet | IgE | Lab | 15 | 31 | 6 | 3 | |||
Amniotic fluid leak | Obtained with panty liner | Amniotic fluid | Home | 4 | 6 | 2 | 1 | ||
Anaemia | Blood obtained with lancet | Haemoglobin | Home | 11 | 24 | 5 | 1 | ||
Bacterial vaginosis | Vaginal swab | pH/alkali amines | Home | 5 | 9 | 1 | 1 | ||
Bowel disorders | Stool obtained with pad in toilet | Blood | Home | 1 | 15 | 6 | 2 | ||
Stool not otherwise specified | Blood | Home | 6 | 6 | 1 | 1 | |||
Stool obtained by wiping | Blood | Home | 3 | 3 | 1 | 1 | |||
Stool obtained with stick | Blood | Home | 5 | 16 | 4 | 3 | |||
Cardiovascular disease | Blood obtained with lancet | Total, HDL, LDL cholesterol/triglycerides | Lab | 17 | 26 | 1 | 1 | ||
Blood obtained with lancet | Total, HDL cholesterol | Home | 13 | 23 | 7 | 3 | |||
Blood obtained with lancet | Total cholesterol | Home | 3 | 15 | 16 | 9 | |||
Blood obtained with lancet | Homocysteine | Lab | 75 | 75 | 1 | 1 | |||
Chlamydia | Cervical swab | Chlamydia-specific enzyme | Home | 15 | 18 | 4 | 1 | ||
Cervical swab/urine | Chlamydia-specific enzyme/not specified | Home/lab | 26 | 26 | 1 | 1 | |||
Urine | Chlamydia | Lab | 42 | 61 | 4 | 2 | |||
Urine | Not specified | Lab | 40 | 40 | 1 | 1 | |||
Chlamydia/gonorrhoea | Urine | Chlamydia/gonorrhoea | Lab | 30 | 38 | 2 | 1 | ||
Urine | Not specified | Lab | 33 | 36 | 2 | 1 | |||
Chlamydia/group B strep | Urine/vaginal and anal swabs | Chlamydia/group B strep | Lab | 29 | 29 | 1 | 1 | ||
Diabetes | Blood obtained with lancet | Glucose | Home | 3 | 9 | 5 | 3 | ||
Blood obtained with lancet | Ketones | Home | 2 | 2 | 1 | 1 | |||
Urine | Glucose | Home | <1 | 9 | 6 | 5 | |||
Glandular fever | Blood obtained with lancet | Antibodies | Home | 8 | 8 | 1 | 1 | ||
Gonorrhoea | Urine | Gonorrhoea | Lab | 42 | 61 | 4 | 2 | ||
HIV-infection | Blood obtained with lancet | Antibodies | Home | 9 | 11 | 3 | 2 | ||
HPV | Obtained with tampon | HPV | Lab | 76 | 76 | 1 | 1 | ||
HPV/chlamydia | Obtained with tampon | HPV/chlamydia | Lab | 45 | 45 | 1 | 1 | ||
HPV/chlamydia/gonorrhoea | Obtained with tampon | HPV/chlamydia/gonorrhoea | Lab | 38 | 38 | 1 | 1 | ||
Influenza | Nasal discharge swab | Influenza virus | Home | 14 | 21 | 1 | 1 | ||
Kidney/urinary tract disorders | Urine | Protein | Home | <1 | <1 | 1 | 1 | ||
Kidney disorders | Urine | Albumin | Home | 14 | 14 | 1 | 1 | ||
Urine | Albumin | Lab | 11 | 11 | 1 | 1 | |||
Menopause | Urine | FSH | Home | 2 | 14 | 14 | 11 | ||
Not specified | Urine | Ketones | Home | <1 | <1 | 1 | 1 | ||
Urine or saliva | pH | Home | <1 | <1 | 1 | 1 | |||
Osteoporosis | Urine | Marker | Lab | 43 | 49 | 2 | 2 | ||
Prostate disorders | Blood obtained with lancet | PSA | Home | 2 | 17 | 5 | 4 | ||
Blood obtained with lancet | PSA | Lab | 15 | 28 | 1 | 1 | |||
Reduced fertility | Semen | Sperm quality | Home | 8 | 32 | 11 | 2 | ||
Semen/urine | Sperm quality/FSH | Home | 8 | 8 | 1 | 1 | |||
Urine | FSH | Home | 2 | 15 | 5 | 2 | |||
Stomach disorders | Blood obtained with lancet | Exposure to Helicobacter pylori | Home | 10 | 14 | 2 | 1 | ||
Thrush | Not specified | Not specified | Home | 12 | 13 | 1 | 1 | ||
Urinary tract disorders | Urine | Blood | Home | <1 | <1 | 1 | 1 | ||
UTI | Urine | Multiple parameters | Home | 4 | 4 | 1 | 1 | ||
Vaginal infection | Obtained with panty liner | pH | Home | 6 | 15 | 3 | 1 | ||
Obtained with glove | pH | Home | <1 | <1 | 1 | 1 | |||
Multiple disorders | Urine | Multiple parameters | Home | <1 | 6 | 11 | 11 | ||
Total | 167 | 104 |
Condition described as being related to the self-test . | Sample required . | Self-test described as detecting . | Processed at . | Cost per test and condition (£) . | . | Number . | . | ||
---|---|---|---|---|---|---|---|---|---|
. | . | . | . | Minimum . | Maximum . | All . | Unique . | ||
Allergy | Blood obtained with lancet | IgE | Home | 10 | 12 | 13 | 6 | ||
Blood obtained with lancet | IgE | Lab | 15 | 31 | 6 | 3 | |||
Amniotic fluid leak | Obtained with panty liner | Amniotic fluid | Home | 4 | 6 | 2 | 1 | ||
Anaemia | Blood obtained with lancet | Haemoglobin | Home | 11 | 24 | 5 | 1 | ||
Bacterial vaginosis | Vaginal swab | pH/alkali amines | Home | 5 | 9 | 1 | 1 | ||
Bowel disorders | Stool obtained with pad in toilet | Blood | Home | 1 | 15 | 6 | 2 | ||
Stool not otherwise specified | Blood | Home | 6 | 6 | 1 | 1 | |||
Stool obtained by wiping | Blood | Home | 3 | 3 | 1 | 1 | |||
Stool obtained with stick | Blood | Home | 5 | 16 | 4 | 3 | |||
Cardiovascular disease | Blood obtained with lancet | Total, HDL, LDL cholesterol/triglycerides | Lab | 17 | 26 | 1 | 1 | ||
Blood obtained with lancet | Total, HDL cholesterol | Home | 13 | 23 | 7 | 3 | |||
Blood obtained with lancet | Total cholesterol | Home | 3 | 15 | 16 | 9 | |||
Blood obtained with lancet | Homocysteine | Lab | 75 | 75 | 1 | 1 | |||
Chlamydia | Cervical swab | Chlamydia-specific enzyme | Home | 15 | 18 | 4 | 1 | ||
Cervical swab/urine | Chlamydia-specific enzyme/not specified | Home/lab | 26 | 26 | 1 | 1 | |||
Urine | Chlamydia | Lab | 42 | 61 | 4 | 2 | |||
Urine | Not specified | Lab | 40 | 40 | 1 | 1 | |||
Chlamydia/gonorrhoea | Urine | Chlamydia/gonorrhoea | Lab | 30 | 38 | 2 | 1 | ||
Urine | Not specified | Lab | 33 | 36 | 2 | 1 | |||
Chlamydia/group B strep | Urine/vaginal and anal swabs | Chlamydia/group B strep | Lab | 29 | 29 | 1 | 1 | ||
Diabetes | Blood obtained with lancet | Glucose | Home | 3 | 9 | 5 | 3 | ||
Blood obtained with lancet | Ketones | Home | 2 | 2 | 1 | 1 | |||
Urine | Glucose | Home | <1 | 9 | 6 | 5 | |||
Glandular fever | Blood obtained with lancet | Antibodies | Home | 8 | 8 | 1 | 1 | ||
Gonorrhoea | Urine | Gonorrhoea | Lab | 42 | 61 | 4 | 2 | ||
HIV-infection | Blood obtained with lancet | Antibodies | Home | 9 | 11 | 3 | 2 | ||
HPV | Obtained with tampon | HPV | Lab | 76 | 76 | 1 | 1 | ||
HPV/chlamydia | Obtained with tampon | HPV/chlamydia | Lab | 45 | 45 | 1 | 1 | ||
HPV/chlamydia/gonorrhoea | Obtained with tampon | HPV/chlamydia/gonorrhoea | Lab | 38 | 38 | 1 | 1 | ||
Influenza | Nasal discharge swab | Influenza virus | Home | 14 | 21 | 1 | 1 | ||
Kidney/urinary tract disorders | Urine | Protein | Home | <1 | <1 | 1 | 1 | ||
Kidney disorders | Urine | Albumin | Home | 14 | 14 | 1 | 1 | ||
Urine | Albumin | Lab | 11 | 11 | 1 | 1 | |||
Menopause | Urine | FSH | Home | 2 | 14 | 14 | 11 | ||
Not specified | Urine | Ketones | Home | <1 | <1 | 1 | 1 | ||
Urine or saliva | pH | Home | <1 | <1 | 1 | 1 | |||
Osteoporosis | Urine | Marker | Lab | 43 | 49 | 2 | 2 | ||
Prostate disorders | Blood obtained with lancet | PSA | Home | 2 | 17 | 5 | 4 | ||
Blood obtained with lancet | PSA | Lab | 15 | 28 | 1 | 1 | |||
Reduced fertility | Semen | Sperm quality | Home | 8 | 32 | 11 | 2 | ||
Semen/urine | Sperm quality/FSH | Home | 8 | 8 | 1 | 1 | |||
Urine | FSH | Home | 2 | 15 | 5 | 2 | |||
Stomach disorders | Blood obtained with lancet | Exposure to Helicobacter pylori | Home | 10 | 14 | 2 | 1 | ||
Thrush | Not specified | Not specified | Home | 12 | 13 | 1 | 1 | ||
Urinary tract disorders | Urine | Blood | Home | <1 | <1 | 1 | 1 | ||
UTI | Urine | Multiple parameters | Home | 4 | 4 | 1 | 1 | ||
Vaginal infection | Obtained with panty liner | pH | Home | 6 | 15 | 3 | 1 | ||
Obtained with glove | pH | Home | <1 | <1 | 1 | 1 | |||
Multiple disorders | Urine | Multiple parameters | Home | <1 | 6 | 11 | 11 | ||
Total | 167 | 104 |
FSH, follicle stimulating hormone; HDL, high-density lipoprotein; HPV, human papillomavirus; IgE, immunoglobulin E; LDL, low-density lipoprotein; PSA, prostate-specific antigen; UTI, urinary tract infection.
Condition described as being related to the self-test . | Sample required . | Self-test described as detecting . | Processed at . | Cost per test and condition (£) . | . | Number . | . | ||
---|---|---|---|---|---|---|---|---|---|
. | . | . | . | Minimum . | Maximum . | All . | Unique . | ||
Allergy | Blood obtained with lancet | IgE | Home | 10 | 12 | 13 | 6 | ||
Blood obtained with lancet | IgE | Lab | 15 | 31 | 6 | 3 | |||
Amniotic fluid leak | Obtained with panty liner | Amniotic fluid | Home | 4 | 6 | 2 | 1 | ||
Anaemia | Blood obtained with lancet | Haemoglobin | Home | 11 | 24 | 5 | 1 | ||
Bacterial vaginosis | Vaginal swab | pH/alkali amines | Home | 5 | 9 | 1 | 1 | ||
Bowel disorders | Stool obtained with pad in toilet | Blood | Home | 1 | 15 | 6 | 2 | ||
Stool not otherwise specified | Blood | Home | 6 | 6 | 1 | 1 | |||
Stool obtained by wiping | Blood | Home | 3 | 3 | 1 | 1 | |||
Stool obtained with stick | Blood | Home | 5 | 16 | 4 | 3 | |||
Cardiovascular disease | Blood obtained with lancet | Total, HDL, LDL cholesterol/triglycerides | Lab | 17 | 26 | 1 | 1 | ||
Blood obtained with lancet | Total, HDL cholesterol | Home | 13 | 23 | 7 | 3 | |||
Blood obtained with lancet | Total cholesterol | Home | 3 | 15 | 16 | 9 | |||
Blood obtained with lancet | Homocysteine | Lab | 75 | 75 | 1 | 1 | |||
Chlamydia | Cervical swab | Chlamydia-specific enzyme | Home | 15 | 18 | 4 | 1 | ||
Cervical swab/urine | Chlamydia-specific enzyme/not specified | Home/lab | 26 | 26 | 1 | 1 | |||
Urine | Chlamydia | Lab | 42 | 61 | 4 | 2 | |||
Urine | Not specified | Lab | 40 | 40 | 1 | 1 | |||
Chlamydia/gonorrhoea | Urine | Chlamydia/gonorrhoea | Lab | 30 | 38 | 2 | 1 | ||
Urine | Not specified | Lab | 33 | 36 | 2 | 1 | |||
Chlamydia/group B strep | Urine/vaginal and anal swabs | Chlamydia/group B strep | Lab | 29 | 29 | 1 | 1 | ||
Diabetes | Blood obtained with lancet | Glucose | Home | 3 | 9 | 5 | 3 | ||
Blood obtained with lancet | Ketones | Home | 2 | 2 | 1 | 1 | |||
Urine | Glucose | Home | <1 | 9 | 6 | 5 | |||
Glandular fever | Blood obtained with lancet | Antibodies | Home | 8 | 8 | 1 | 1 | ||
Gonorrhoea | Urine | Gonorrhoea | Lab | 42 | 61 | 4 | 2 | ||
HIV-infection | Blood obtained with lancet | Antibodies | Home | 9 | 11 | 3 | 2 | ||
HPV | Obtained with tampon | HPV | Lab | 76 | 76 | 1 | 1 | ||
HPV/chlamydia | Obtained with tampon | HPV/chlamydia | Lab | 45 | 45 | 1 | 1 | ||
HPV/chlamydia/gonorrhoea | Obtained with tampon | HPV/chlamydia/gonorrhoea | Lab | 38 | 38 | 1 | 1 | ||
Influenza | Nasal discharge swab | Influenza virus | Home | 14 | 21 | 1 | 1 | ||
Kidney/urinary tract disorders | Urine | Protein | Home | <1 | <1 | 1 | 1 | ||
Kidney disorders | Urine | Albumin | Home | 14 | 14 | 1 | 1 | ||
Urine | Albumin | Lab | 11 | 11 | 1 | 1 | |||
Menopause | Urine | FSH | Home | 2 | 14 | 14 | 11 | ||
Not specified | Urine | Ketones | Home | <1 | <1 | 1 | 1 | ||
Urine or saliva | pH | Home | <1 | <1 | 1 | 1 | |||
Osteoporosis | Urine | Marker | Lab | 43 | 49 | 2 | 2 | ||
Prostate disorders | Blood obtained with lancet | PSA | Home | 2 | 17 | 5 | 4 | ||
Blood obtained with lancet | PSA | Lab | 15 | 28 | 1 | 1 | |||
Reduced fertility | Semen | Sperm quality | Home | 8 | 32 | 11 | 2 | ||
Semen/urine | Sperm quality/FSH | Home | 8 | 8 | 1 | 1 | |||
Urine | FSH | Home | 2 | 15 | 5 | 2 | |||
Stomach disorders | Blood obtained with lancet | Exposure to Helicobacter pylori | Home | 10 | 14 | 2 | 1 | ||
Thrush | Not specified | Not specified | Home | 12 | 13 | 1 | 1 | ||
Urinary tract disorders | Urine | Blood | Home | <1 | <1 | 1 | 1 | ||
UTI | Urine | Multiple parameters | Home | 4 | 4 | 1 | 1 | ||
Vaginal infection | Obtained with panty liner | pH | Home | 6 | 15 | 3 | 1 | ||
Obtained with glove | pH | Home | <1 | <1 | 1 | 1 | |||
Multiple disorders | Urine | Multiple parameters | Home | <1 | 6 | 11 | 11 | ||
Total | 167 | 104 |
Condition described as being related to the self-test . | Sample required . | Self-test described as detecting . | Processed at . | Cost per test and condition (£) . | . | Number . | . | ||
---|---|---|---|---|---|---|---|---|---|
. | . | . | . | Minimum . | Maximum . | All . | Unique . | ||
Allergy | Blood obtained with lancet | IgE | Home | 10 | 12 | 13 | 6 | ||
Blood obtained with lancet | IgE | Lab | 15 | 31 | 6 | 3 | |||
Amniotic fluid leak | Obtained with panty liner | Amniotic fluid | Home | 4 | 6 | 2 | 1 | ||
Anaemia | Blood obtained with lancet | Haemoglobin | Home | 11 | 24 | 5 | 1 | ||
Bacterial vaginosis | Vaginal swab | pH/alkali amines | Home | 5 | 9 | 1 | 1 | ||
Bowel disorders | Stool obtained with pad in toilet | Blood | Home | 1 | 15 | 6 | 2 | ||
Stool not otherwise specified | Blood | Home | 6 | 6 | 1 | 1 | |||
Stool obtained by wiping | Blood | Home | 3 | 3 | 1 | 1 | |||
Stool obtained with stick | Blood | Home | 5 | 16 | 4 | 3 | |||
Cardiovascular disease | Blood obtained with lancet | Total, HDL, LDL cholesterol/triglycerides | Lab | 17 | 26 | 1 | 1 | ||
Blood obtained with lancet | Total, HDL cholesterol | Home | 13 | 23 | 7 | 3 | |||
Blood obtained with lancet | Total cholesterol | Home | 3 | 15 | 16 | 9 | |||
Blood obtained with lancet | Homocysteine | Lab | 75 | 75 | 1 | 1 | |||
Chlamydia | Cervical swab | Chlamydia-specific enzyme | Home | 15 | 18 | 4 | 1 | ||
Cervical swab/urine | Chlamydia-specific enzyme/not specified | Home/lab | 26 | 26 | 1 | 1 | |||
Urine | Chlamydia | Lab | 42 | 61 | 4 | 2 | |||
Urine | Not specified | Lab | 40 | 40 | 1 | 1 | |||
Chlamydia/gonorrhoea | Urine | Chlamydia/gonorrhoea | Lab | 30 | 38 | 2 | 1 | ||
Urine | Not specified | Lab | 33 | 36 | 2 | 1 | |||
Chlamydia/group B strep | Urine/vaginal and anal swabs | Chlamydia/group B strep | Lab | 29 | 29 | 1 | 1 | ||
Diabetes | Blood obtained with lancet | Glucose | Home | 3 | 9 | 5 | 3 | ||
Blood obtained with lancet | Ketones | Home | 2 | 2 | 1 | 1 | |||
Urine | Glucose | Home | <1 | 9 | 6 | 5 | |||
Glandular fever | Blood obtained with lancet | Antibodies | Home | 8 | 8 | 1 | 1 | ||
Gonorrhoea | Urine | Gonorrhoea | Lab | 42 | 61 | 4 | 2 | ||
HIV-infection | Blood obtained with lancet | Antibodies | Home | 9 | 11 | 3 | 2 | ||
HPV | Obtained with tampon | HPV | Lab | 76 | 76 | 1 | 1 | ||
HPV/chlamydia | Obtained with tampon | HPV/chlamydia | Lab | 45 | 45 | 1 | 1 | ||
HPV/chlamydia/gonorrhoea | Obtained with tampon | HPV/chlamydia/gonorrhoea | Lab | 38 | 38 | 1 | 1 | ||
Influenza | Nasal discharge swab | Influenza virus | Home | 14 | 21 | 1 | 1 | ||
Kidney/urinary tract disorders | Urine | Protein | Home | <1 | <1 | 1 | 1 | ||
Kidney disorders | Urine | Albumin | Home | 14 | 14 | 1 | 1 | ||
Urine | Albumin | Lab | 11 | 11 | 1 | 1 | |||
Menopause | Urine | FSH | Home | 2 | 14 | 14 | 11 | ||
Not specified | Urine | Ketones | Home | <1 | <1 | 1 | 1 | ||
Urine or saliva | pH | Home | <1 | <1 | 1 | 1 | |||
Osteoporosis | Urine | Marker | Lab | 43 | 49 | 2 | 2 | ||
Prostate disorders | Blood obtained with lancet | PSA | Home | 2 | 17 | 5 | 4 | ||
Blood obtained with lancet | PSA | Lab | 15 | 28 | 1 | 1 | |||
Reduced fertility | Semen | Sperm quality | Home | 8 | 32 | 11 | 2 | ||
Semen/urine | Sperm quality/FSH | Home | 8 | 8 | 1 | 1 | |||
Urine | FSH | Home | 2 | 15 | 5 | 2 | |||
Stomach disorders | Blood obtained with lancet | Exposure to Helicobacter pylori | Home | 10 | 14 | 2 | 1 | ||
Thrush | Not specified | Not specified | Home | 12 | 13 | 1 | 1 | ||
Urinary tract disorders | Urine | Blood | Home | <1 | <1 | 1 | 1 | ||
UTI | Urine | Multiple parameters | Home | 4 | 4 | 1 | 1 | ||
Vaginal infection | Obtained with panty liner | pH | Home | 6 | 15 | 3 | 1 | ||
Obtained with glove | pH | Home | <1 | <1 | 1 | 1 | |||
Multiple disorders | Urine | Multiple parameters | Home | <1 | 6 | 11 | 11 | ||
Total | 167 | 104 |
FSH, follicle stimulating hormone; HDL, high-density lipoprotein; HPV, human papillomavirus; IgE, immunoglobulin E; LDL, low-density lipoprotein; PSA, prostate-specific antigen; UTI, urinary tract infection.
The self-tests required various samples: blood, stool, saliva, semen, urine or vaginal discharge. Where a blood sample was required, this was a finger prick sample obtained using a lancet. The samples were processed at home with results available in minutes or sent to a laboratory for processing with results returned by e-mail or post after several days.
Prices per self-test and condition, including postage or shipping where this information was available, ranged from <£1 for various urine tests or a test for vaginal infection to £76 for a test for human papillomavirus. Over 80% (n = 86) of the 104 unique self-tests had a maximum price of <£30.
Discussion
Main findings of this study
This study demonstrates that a wide range of self-tests are available, many at a reasonable price.
What is already known on this topic
Although previous articles mention that self-tests are available,1,6 we have not been able to identify any systematic study detailing their availability in the United Kingdom. A comprehensive literature review also identified only one recent survey in the United Kingdom that asked about the use of home-testing kits, and this was part of a study on attitudes to genetic testing.3 In that survey, the respondents were asked whether they had bought a health-testing kit to carry out at home with pregnancy tests cited as an example. Thirty-two percent of the 2510 respondents said that they had done so, but the question did not specify whether the test was to monitor an existing condition or diagnose a new condition, and the response rate was only 44%.
What this study adds
This study demonstrates the potential for self-testing for a wide range of conditions by members of the UK public. People can find out about self-tests using the Internet, and purchase of such tests is fairly straightforward and does not require consultation with a health professional. Self-tests do have potential benefits, for example privacy and convenience, but they may also have potential harms, for example distress caused by false-positive results2 or risks associated with false-negative results. Other potential problems include extra pressure on primary health care professionals and NHS laboratories because people seek an explanation of results or further investigation.7 A recent British Medical Association report highlighted that ad hoc screening can put people at risk because of a lack of evidence underpinning tests and insufficient quality assurance and accompanying information.8
Limitations of this study
We wanted to identify tests that involve a change in behaviour from diagnosis in a professional setting to diagnosis in a lay setting, and inclusion and exclusion criteria were developed based on this. We included tests that required the user to take a sample because we felt that this has previously been viewed as the domain of the professional, whereas pregnancy tests were excluded because women have used them for some time and their use is probably now expected by doctors. Although this study sets a baseline and indicates availability within these stated criteria, the appropriate criteria may need refinement in the future as further tests are developed. Our criteria exclude self-initiated imaging or screening tests based on, for example, changes in mental state or perception, but an Early Alert Alzheimer’s Home Screening Test has already been reported as being available in the United States based on scratch-and-sniff style scents.9
We attempted to verify that each self-test that we identified could be purchased by a member of the UK public, but it was not always possible to do so without actually purchasing the test. We may, therefore, have erroneously included a small number of tests where the retailer would only refuse to ship to the United Kingdom after credit card details were submitted. Even so, the identification of nine retailers in the United Kingdom is an indication of the general level of availability. Furthermore, this study was systematic rather than exhaustive, and there are likely to be other self-tests that were not identified during this study.
Retailers provided varying amounts of information on their websites. Even with our background knowledge, it was sometimes difficult to determine from the information provided exactly what the test detected, what doing the test involved and the sample that was required. Although we tried to determine the number of unique tests that were available by looking for duplicate tests, we were limited by the amount of descriptive information available from some retailers.
Conclusions
Self-tests are widely available. We are currently conducting a study to describe the prevalence of their use and factors associated with using them, but further work is needed to assess the impact of self-test use on individuals, the population and health services.
Contributors
All authors were responsible for the overall design of this study. A.R., S.C., S.G. and S.W. designed the Internet search. S.C. conducted a preliminary Internet search, and A.R. conducted the full Internet search and collected details of eligible self-tests. A.R. collated the data and prepared the report with input from all authors.
Competing interest
None.
Acknowledgements
We thank the other members of the Self-Test Study Steering Group, Cyril Chapman, David Fitzmaurice and John Marriott, for commenting on the design of this study.
Funding A.R. holds a Department of Health Researcher Development Award. S.W. holds a Department of Health Career Scientist Award.
References
YouGov Limited.
iProspect. Search Engine User Behavior Study.
Human Genetics Commission.
British Medical Association Board of Science. Population screening and genetic testing. A briefing on current programmes and technologies. London,